RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling-Reference-Cited by-同舟云学术

RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling

Published:2018-05-29 Issue:37 Volume:37 Page:5101-5114
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Sirinian Chaido,Papanastasiou Anastasios D.,Schizas Michail,Spella Magda,Stathopoulos Georgios T.^ORCID,Repanti Maria,Zarkadis Ioannis K.,King Tari A.,Kalofonos Haralabos P.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-018-0324-y.pdf

Reference48 articles.

1. Papanastasiou AD, Sirinian C, Kalofonos HP, Repanti M. Current therapeutic leads for the treatment of melanoma: targeted immunotherapy in the post-genomic era. Curr Mol Pharmacol. 2014;7:33–43.

2. Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchio C, Reis-Filho JS. Breast cancer precursors revisited: molecular features and progression pathways. Histopathology. 2010;57:171–92.

3. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747–52.

4. Sotiriou C, Pusztai L. Gene-expression signatures in breast cancer. N Engl J Med. 2009;360:790–800.

5. Weigelt B, Baehner FL, Reis-Filho JS. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J Pathol. 2010;220:263–80.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of oxazine-linked pyrimidine as an inhibitor of breast cancer growth and metastasis by abrogating NF-κB activation;Frontiers in Oncology;2024-07-29

2. TRAF6 as a potential target in advanced breast cancer: a systematic review, meta-analysis, and bioinformatics validation;Scientific Reports;2023-03-21

3. Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand/receptor activator of nuclear factor kappa-B signaling;Frontiers in Cell and Developmental Biology;2022-11-03

4. Analysis of RANK-c interaction partners identifies TRAF3 as a critical regulator of breast cancer aggressiveness;Neoplasia;2022-11

5. Dysregulation of splicing variants and spliceosome components in breast cancer;Endocrine-Related Cancer;2022-09-01